23.08.2013 Dr. Hönle AG  DE0005157101

DGAP-News: Hönle generates operating result of EUR 5.3 million


 
DGAP-News: Dr. Hönle AG / Key word(s): Quarter Results Hönle generates operating result of EUR 5.3 million 23.08.2013 / 05:00 --------------------------------------------------------------------- Sales revenues earned by the Hönle Group increased from TEUR 51,725 in the previous year to TEUR 55,531 in the first nine months of financial year 2012/2013 due to acquisitions. The corporate group generated an operating result (EBIT) of TEUR 5.330 after TEUR 5,316 in the comparable previous year's period. Pre-tax earnings amount to TEUR 4,841 (PY: TEUR 4,961), and consolidated net earnings came to TEUR 3,589 (PY: TEUR 3,285), which corresponds to earnings per share of EUR 0.63 (PY: EUR 0.55). The EBIT margin thus stood at 9.4 % in the current financial year, compared to 10.3 % in the previous year. Net profit on sales remained almost constant at 6.5 % (PY: 6.4 %). The Hönle Group's equity ratio was 60.9 % (PY: 59.8 %). Outlook: 'Equipment and Systems' segment Grafix GmbH, which has been included in the Hönle Group since 8 January 2013, already contributed positively to earnings during the first six months of consolidation despite the one-time expenses incurred within the scope of integration. Management assumes positive development in the printing segment for the coming quarters and stable sales developments are also expected for UV and IR systems in offset printing. Moreover, the Grafix acquisition may provide positive effects. Sales growth is assumed for digital printing applications as the Hönle Group is excellently positioned on the growing digital printing market. The trade fair, China Print, which is an important event for the printing industry, opened its doors in May and may further boost sales in the field of printing applications in the coming quarters. 'Glass and Lamps' segment The Raesch Group initiated a comprehensive package of measures to improve the sales and earnings level, which included expansion of sales activities through both new sales partnerships on the North-American sales market and the hiring of additional personnel to support its own sales team. In addition, Raesch has developed and launched new products with a view to further tapping the semi-conductor market, among others. Emphasis is also placed on optimizing the proportion of rejects and on a pertaining improvement in the cost of materials ratio. The resulting effects will probably have a positive impact from the beginning of the next financial year. Management assumes that the semiconductor market will recover gradually during the next quarters. 'Adhesives' segment The course of business in the 'Adhesives' segment saw encouraging development. Customer orders received from the electronics industry will contribute to significant sales and earnings increases in this segment in the fourth quarter. Additional personnel were hired in the sales and development departments with a view to boosting sales. Here, the focus is on further tapping existing sales potential in the entertainment electronics and optoelectronics industries and in the automotive industry. In addition, the medical technology sector is to be expanded further. Expanding sales in the North American and Chinese sales territories through investments in Tangent Industries Inc. and Hoenle UV Technology (Shanghai) Trading Ltd., is in planning. With its three business segment, 'Equipment and System', 'Glass and Lamps' and 'Adhesives', the Hönle Group is very well positioned. At the same time the corporate group is represented in markets which provide strong potential for further growth. Management therefore adheres to its objective of reaching the EUR 100 million sales threshold in two years. Starting with its previous statement that sales of between EUR 75 and 80 million and an operating result of between EUR 8 and 9 million will be achieved, the Hönle Group Management presently assumes that the respective lower limit of the target corridor will be reached. About Hönle: Dr. Hönle AG is a listed technology company with head office in Gräfelfing, near Munich. With a staff level of ca. 500 employees, the Hönle Group is one of the world's leading systems suppliers in the UV technology segment. The equipment and systems are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and in the simulation of natural sunlight. The Company's business activities also include the development and sale of industrial adhesives and casting compounds. In addition, the Group manufactures UV lamps that are used in water sterilisation and for other applications, and produces tubing and semi-finished goods made of quartz glass that are used by various branches of industry. The Hönle Group is represented worldwide at 50 locations in more than 20 countries by own companies and sales partners. Contact: Peter Weinert, Tel. +49 89 85608 173, E-Mail [email protected] End of Corporate News --------------------------------------------------------------------- 23.08.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Dr. Hönle AG Lochhamer Schlag 1 82166 Gräfelfing Germany Phone: +49 (0)89 85608 0 Fax: +49 (0)89 85608 148 E-mail: [email protected] Internet: www.hoenle.de ISIN: DE0005157101 WKN: 515710 Indices: Technology All Share Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 227142 23.08.2013


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 101,93 126,49 107,75 93,88 115,17 126,50 106,34
EBITDA1,2 18,14 33,84 20,32 14,71 13,85 15,40 0,33
EBITDA-Marge3 17,80 26,75 18,86 15,67 12,03 12,17
EBIT1,4 15,21 30,69 17,00 8,10 0,35 -10,10 -9,42
EBIT-Marge5 14,92 24,26 15,78 8,63 0,30 -7,98 -8,86
Jahresüberschuss1 10,41 21,73 12,40 5,61 -4,86 -11,90 -10,93
Netto-Marge6 10,21 17,18 11,51 5,98 -4,22 -9,41 -10,28
Cashflow1,7 12,15 27,88 23,06 16,61 1,13 -6,00 3,14
Ergebnis je Aktie8 1,89 3,84 2,26 1,02 -0,80 -2,20 -1,82
Dividende8 0,60 0,80 0,80 0,50 0,20 0,00 0,55
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: RSM Ebner Stolz

INVESTOR-INFORMATIONEN
©boersengefluester.de
Dr. Hönle
WKN Kurs in € Einschätzung Börsenwert in Mio. €
515710 19,450 Kaufen 117,92
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
16,91 19,15 0,87 23,43
KBV KCV KUV EV/EBITDA
1,23 37,52 1,11 510,84
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 20.03.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
26.02.2024 08.05.2024 07.08.2024 30.01.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
10,93% 2,69% 11,14% 1,94%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Dr. Hönle AG  ISIN: DE0005157101 können Sie bei EQS abrufen


Spezialmaschinenbau , 515710 , HNL , XETR:HNL